Medicare Enrolled
Dr. Seong Kim, MD
Hematology & Oncology · Los Angeles, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kim from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kim?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kim
Dr. Seong Kim is a hematology & oncology specialist in Los Angeles, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Kim performed 2,506 Medicare services across 1,034 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kim received a total of $13,910 from 88 pharmaceutical and/or device companies across 623 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kim is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 39% volume in CA
$13,910 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,506
Medicare services
Top 39% in CA for hematology & oncology
1,034
Unique beneficiaries
$28
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~132 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
634 | $0 | $0 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
369 | $97 | $423 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
166 | $8 | $26 |
| Anti-nausea injection (ondansetron/Zofran) | 138 | $0 | $0 |
| Immune globulin infusion (Octagam) This procedure involves the administration of immune globulin medication directly into a vein. It is provided in a non-lyophilized liquid form. |
136 | $29 | $114 |
| Anti-nausea injection (Aloxi/palonosetron) | 132 | $1 | $2 |
| Assessment of emotional or behavioral problems An evaluation to identify and understand emotional or behavioral issues. This process involves reviewing symptoms and behaviors to determine the nature of the concerns. |
111 | $4 | $17 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
108 | $25 | $101 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
85 | $0 | $1 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
74 | $8 | $12 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
74 | $112 | $468 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
74 | $75 | $284 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
66 | $10 | $34 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
58 | $1 | $4 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
52 | $11 | $48 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
50 | $58 | $227 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
41 | $17 | $71 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
36 | $27 | $115 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
36 | $56 | $229 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
27 | $11 | $44 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
26 | $24 | $99 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
13 | $145 | $571 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
21.5% high complexity
42.6% medium
35.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$13,910
Total received (2018-2024)
Avg $1,987/year across 7 years
Top 27% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
88
Companies
623
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,710 (98.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$200 (1.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$270
2023
$4,236
2022
$2,734
2021
$1,947
2020
$1,794
2019
$1,617
2018
$1,311
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$118
Novartis Pharmaceuticals Corporation
$78
Astellas Pharma US Inc
$26
BeiGene USA, Inc.
$26
Bayer Healthcare Pharmaceuticals Inc.
$22
Top 3 companies account for 82.2% of 2024 payments
All-time payments by company (2018-2024) ›
E.R. Squibb & Sons, L.L.C.
$1,162
Amgen Inc.
$931
AstraZeneca Pharmaceuticals LP
$788
Incyte Corporation
$717
Novartis Pharmaceuticals Corporation
$609
Takeda Pharmaceuticals U.S.A., Inc.
$585
PFIZER INC.
$574
GENZYME CORPORATION
$452
Celgene Corporation
$449
Karyopharm Therapeutics Inc.
$446
Genentech USA, Inc.
$440
Seagen Inc.
$418
Bayer HealthCare Pharmaceuticals Inc.
$356
Janssen Biotech, Inc.
$320
GlaxoSmithKline, LLC.
$290
Astellas Pharma US Inc
$269
Exelixis Inc.
$240
TerSera Therapeutics LLC
$211
Boehringer Ingelheim Pharmaceuticals, Inc.
$195
Pharmacyclics LLC, An AbbVie Company
$194
Alexion Pharmaceuticals, Inc.
$193
TOLMAR Pharmaceuticals, Inc.
$176
Eisai Inc.
$169
Regeneron Healthcare Solutions, Inc.
$166
Pharmacosmos Therapeutics Inc.
$158
Dova Pharmaceuticals
$152
Daiichi Sankyo Inc.
$146
Janssen Scientific Affairs, LLC
$145
PharmaEssentia USA Corporation
$142
Blueprint Medicines Corporation
$140
Bayer Healthcare Pharmaceuticals Inc.
$125
Merck Sharp & Dohme LLC
$124
Gilead Sciences, Inc.
$118
BeiGene USA, Inc.
$115
Merck Sharp & Dohme Corporation
$108
Lilly USA, LLC
$106
Seattle Genetics, Inc.
$94
Coherus Biosciences Inc.
$90
TESARO, Inc.
$90
Taiho Oncology, Inc.
$89
PUMA BIOTECHNOLOGY, INC.
$86
Genmab U.S., Inc.
$85
Clovis Oncology, Inc.
$81
G1 Therapeutics, Inc.
$70
Rigel Pharmaceuticals, Inc.
$69
Sun Pharmaceutical Industries Inc.
$58
JAZZ PHARMACEUTICALS INC.
$53
ARRAY BIOPHARMA INC
$51
Organon LLC
$48
TAIHO ONCOLOGY, INC.
$48
Puma Biotechnology, Inc.
$47
MorphoSys, US Inc.
$45
EISAI INC.
$44
Shire North American Group Inc
$43
EMD Serono, Inc.
$42
Verastem, Inc.
$40
SOBI, INC
$33
Adaptive Biotechnologies Corporation
$31
Stemline Therapeutics Inc.
$30
Sobi, Inc
$30
Myovant Sciences Inc.
$29
Secura Bio, Inc.
$29
AVEO Pharmaceuticals, Inc.
$28
ImmunoGen, Inc.
$26
ABBVIE INC.
$26
Tolmar, Inc.
$25
SANOFI-AVENTIS U.S. LLC
$25
Immunomedics, Inc.
$25
Global Blood Therapeutics, Inc.
$24
Agios Pharmaceuticals, Inc.
$23
Octapharma USA, Inc.
$22
INSYS Therapeutics Inc
$22
Roche Molecular Systems, Inc.
$22
Chiesi USA, Inc.
$21
Jazz Pharmaceuticals Inc.
$21
Kyowa Kirin, Inc.
$20
EUSA Pharma (US) LLC
$20
Acrotech Biopharma Inc.
$19
Emmaus Medical, Inc.
$19
MEDIVATION FIELD SOLUTIONS LLC
$19
Teva Pharmaceuticals USA, Inc.
$18
Heron Therapeutics, Inc.
$18
Mirati Therapeutics, Inc.
$17
Cumberland Pharmaceuticals, Inc.
$15
Sirtex Medical Inc
$14
Novocure Inc.
$14
Mylan Institutional Inc.
$13
Advanced Accelerator Applications
$13
Top 3 companies account for 20.7% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · AYVAKIT · BAVENCIO · BELEODAQ · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · COSELA · CYRAMZA · Cabometyx · Copiktra · DARZALEX · DIAGNOSTICS INFORMATION SYSTEMS · DOPTELET · Doptelet · ELIGARD · ELITEK · EMPLICITI · ENHERTU · ERBITUX · ERLEADA · EVENITY · Elahere · Endari · Enhertu · Epkinly · Erleada · FARYDAK · FASLODEX · FERRIPROX · FOTIVDA · Farydak · GAVRETO · GILOTRIF · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LUMAKRAS · LYNPARZA · Lenvima · Lonsurf · Lutathera · MEKINIST · MONJUVI · MONOFERRIC · MVASI · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Ogivri · Oncology · Orserdu · PADCEV · PLUVICTO · POTELIGEO · PROMACTA · PYRUKYND · Padcev · Phesgo · Pomalyst · Prolia · Quzyttir · REBLOZYL · RETACRIT · RYBREVANT · RYDAPT · Revlimid · Rubraca · SANCUSO · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOLIRIS · SPRYCEL · SUSTOL · SUTENT · SYNDROS · Stivarga · Sylvant · TABRECTA · TALZENNA · TASIGNA · TECENTRIQ · TIVDAK · TUKYSA · Tavalisse · Trodelvy · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VOTRIENT · Vectibix · Venclexta · Vitrakvi · Vyloy · XALKORI · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · YONSA · ZEJULA · ZEPZELCA · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
406
Per 100K population
4.1
County median income
$87,760
Nearest hospital
PIH HEALTH GOOD SAMARITAN HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kim is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kim experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Kim performed 634 dexamethasone injection (steroid) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kim receive payments from pharmaceutical companies?
Yes. Dr. Kim received a total of $13,910 from 88 companies across 623 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kim's costs compare to other hematology & oncology specialists in Los Angeles?
Dr. Kim's average Medicare payment per service is $28. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kim) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Los Angeles
Browse hematology & oncology specialists in Los Angeles ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology